Analysis of the patients diagnosed as hypoplastic left heart syndrome at prenatal period. Perinatal Journal 2014;22(2):88-92
- Başkent Üniversitesi Adana Hastanesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Perinatoloji Bilim Dalı- Adana TR
- Başkent Üniversitesi Ankara Hastanesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Perinatoloji Bilim Dalı- Ankara TR
Hakan Kalaycı, Başkent Üniversitesi Adana Hastanesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Perinatoloji Bilim Dalı- Adana TR, [email protected]
Manuscript Received: December 17, 2013
Manuscript Accepted: March 09, 2014
Conflicts of Interest
No conflicts declared.
The aim of this study was to analyze patients together with their demographic data who are diagnosed with hypoplastic left heart syndrome at intrauterine period.
In this study, 29 pregnant women who were referred from other centers to or followed-up in the Divisions of Perinatology of Ankara and Adana hospitals of Başkent University between June 2009 and February 2013 were analyzed in terms of their demographic data, diagnosis weeks, concomitant anomalies and the progress of their pregnancies.
Among these cases, there was only one twin pregnancy. Three pregnancies were obtained by assisted reproductive technology (10.3%). When concomitant anomalies were analyzed, additional cardiac anomaly was found as 27.6% (8/29), hydrops as 13.4% (4/29) and single umbilical artery as 10% (2/29). Ten patients (34%) who were diagnosed in our hospital between 18 and 22 weeks of gestation preferred termination. Other patients were just referred to our hospital for delivery by being diagnosed at late period. While 4 (13.7%) of these babies could be in a condition to be operated after delivery, one of two surviving patients waited for second operation and the other one waited for third operation.
In hypoplastic left heart syndrome, to be able to have an operation and chance to survive after delivery seems still low in our country. Early prenatal diagnosis is significant in terms of proper briefing family and the decision for termination.
Hypoplastic left heart, diagnosis, prognosis.
Hypoplastic left heart syndrome (HLHS) is defined as the hypoplasia of the left side of the heart where mitral atresia, aortic atresia, aortic stenosis and coarctation of aorta may also be seen as well. It constitutes 7-9% of congenital cardiac diseases. It is seen in 0.016% to 0.036% of live births,[3-6] and it is responsible for 25% of cardiac-associated deaths in the first week of life. Prenatal diagnosis is based on the fetal echocardiography to be performed between 18 and 24 weeks of gestation.[8,9] In four-chamber view of the heart, ventricle seen as a small globular or narrow gap with endocardial fibroelastosis can be detected.
Various chromosomal diseases (i.e. Turner syndrome) or syndromes (i.e. Noonan syndrome, Smith-Lemli-Opitz syndrome and Holt-Oram syndrome) may accompany the disease.[10,11] Extracardiac anomalies such as omphalocele, corpus callosum agenesis and hydrops fetalis may be observed. Also, additional cardiac defects such as transposition of the great arteries, atrial isomerism, and total abnormal pulmonary venous return anomaly may be observed (7.5%). Today, there are two therapy approaches which are three-step series of univentricular palliation and cardiac transplantation.
In this study, we aimed to analyze retrospectively the demographic data, diagnosis weeks, concomitant anomalies and the progress of the pregnancies of the patients who were diagnosed as HLHS at intrauterine period.
In this study, 29 pregnant women who were referred from other centers to or followed-up in the Divisions of Perinatology of Ankara and Adana hospitals of Başkent University between June 2009 and February 2013 were analyzed in terms of their demographic data, diagnosis weeks, concomitant anomalies and the progress of their pregnancies. Statistical data was evaluated by SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
Only 10.3% of mothers were 35 years old and above, and only one of them had twin pregnancy. Three pregnancies were obtained by assisted reproductive technology (10.3%). When concomitant anomalies were analyzed, additional cardiac anomaly was found as 27.6% (8/29), hydrops as 13.4% (4/29) and single umbilical artery as 10% (2/29). Only one patient had trisomy 21. Nineteen (65.5%) patients were diagnosed between 18 and 24 weeks of gestation but only ten of them (34%) preferred termination. Other patients were just referred to our hospital for delivery by being diagnosed at late period. While 4 (13.7%) of these babies were operated after the delivery, one of two surviving patients has been waiting for second operation and the other one has been waiting for third operation.
For hypoplastic left heart syndrome (HLHS) which responsible for 25% of the cardiac-associated deaths in the first week of life, early diagnosis is very significant to decide for maintaining pregnancy or termination.
Optimal diagnosis is established by examining fetal heart ultrasonographically between 18 and 24 weeks of gestation. In four-chamber view of the heart, ventricle seen as a small globular or narrow gap with endocardial fibroelastosis can be detected (Fig. 1).[8,9] By the Doppler ultrasonography examination in four-chamber view, it can be seen that left ventricle cavity is not filled (Fig. 2), the reverse flow from foramen ovale and even the flow of mitral insufficiency in cases where mitral valve is dysplastic can be observed.
Also, additional cardiac defects such as transposition of the great arteries, atrial isomerism, and total abnormal pulmonary venous return anomaly may be observed together with HLHS (7.5%).
In our study, additional cardiac anomalies were detected in 8 cases (25.7%) which were ventricular septal defect in 3 cases, tricuspid insufficiency in 2 cases, mitral stenosis in one case and abnormal pulmonary venous return anomaly.
It is significant to share the negative impact of associated chromosomal and extracardiac malformations on the prognosis with the family. In a study performed by Allen et al. on 176 cases in 2005, karyotype analyses were conducted on the fetuses (22%) diagnosed. Among these cases, chromosomal anomaly was found in 42% of them. In our case, trisomy 21 was found only in one case as a chromosomal anomaly concomitant to HLHS. Schulz published a case concomitant to Noone syndrome associated with RAF1 gene mutation. In our study, extracardiac anomalies (such as hydrops, single umbilical artery) were found in 17 patients (58.6%). The rate of extracardiac anomaly such as corpus callosum agenesis, diaphragmatic hernia and omphalocele etc. has been reported between 12 and 37% in the literature.[7,12,18-21] We had only four cases decided to maintain the pregnancy and have the chance for operation (13.7%). Two of them are still alive and wait for following operations. During this three-step operation process, first step is Norwood operation. The purpose in this operation is to enable systemic and pulmonary circulation in a balanced way without any obstruction.
The second operation is the step for establishing cavopulmonary shunt performed at 4th-6th months. This procedure is also called as bidirectional Glenn shunt; it is a less risky operation compared to the first step and has a chance of success about 96-99%. One of our patients is prepared for this operation.
The third step is the Fontan operation. It is aimed in this operation to create total cavopulmonary connection. Mortality rate after this operation is reported as about 3-4%.
In a study carried out in 14 centers, 1 year survival rate reported for triple palliation and transplantation operations varies between 30-80% and 5-90%, respectively. Cardiac transplantation may have a life-saver role at each step in the patients who undergone palliation. The rate to reach an adult age is still below 30%.[13,25]
Neurological problems such as learning disability, low IQ level, hyperactivity and lack of attention may be seen in patients with HLHS.[26-31]
Structural and functional brain anomalies may be observed in patients with congenital cardiac disease even during birth. This is probably because of the variability of blood flow on brain and it varies according to the type of congenital cardiac disease.[32-37] Uncertainties in neurological development and long-term life prognosis affect the final decision of parents about fetus.
Szwast et al. found that fetuses with hypoplastic left heart syndrome decreased cerebrovascular resistance in order to maintain cerebral blood flow at third trimester. Information provided to families is very significant in terms of the expectations of families and the progress of pregnancy. Tibballs et al. stated that the rate to choose surgical treatment in patients who are established prenatal diagnosis during pregnancy is higher than the rate of those established postnatal diagnosis (94% and 47%, respectively).
It is all significant in terms of termination of pregnancy, informing family about disease, termination, maintenance of pregnancy and the problems to be faced in future. Two hundred and eleven families who had fetuses with HLHS participated in a survey. Sixty-five percent of them were diagnosed at prenatal period, and 34% of them decided to terminate the pregnancy. Informing families about termination again in the subsequent interviews considerably decreased their optimistic ideas about the life of fetus. Twenty-two percent of the parents stated that they felt a pressure from physicians to terminate the gestation. Thirty-eight percent of the parents looked for a second option, and 69% of them consulted different individuals to choose a new physician.
Hypoplastic left heart syndrome can be diagnosed easily at 18-24 weeks of gestation with today’s advancing technological advantages. With the opportunity for diagnosis to be presented prenatally, families will be more comfortable for making a decision about the prognosis of their fetuses compared to postnatal period. Despite the developed treatment modalities, concomitant extracardiac, additional cardiac and karyotype anomalies and operations which take long will all be effective on families to make a decision about the prognosis of fetus. This situation emphasizes the importance of early diagnosis in Turkey.
1. Simpson JM. Hypoplastic left heart syndrome. Ultrasound Obstet Gynecol 2000;5:271-8.
2. Rice MJ, McDonald RW, Pilu G. Cardiac malformations. In: Nyberg DA, McGahan JP, Pretorius DH, Pilu G, editors. Diagnostic imaging of fetal anomalies. Philadelphia: Lippincott Williams & Wilkins; 2003; p: 451-506.
3. Morris CD, Outcalt J, Menashe VD. Hypoplastic left heart syndrome. Natural history in a geographically defined population. Pediatrics 1990;85:977-83.
4. Samanek M, Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15- year survival. A prospective Bohemia survival study. Pediatr Cardiol 1999;20:411-7.
5. Chameides L, Galioto F, Fyler DC. The Regional Infant Cardiac Program. A six year evaluation. Conn Med 1975;39: 709-10.
6. Brownell LG, Shokeir MH. Inheritance of hypoplastic left heart syndrome (HLHS). Further observations. Clin Genet 1976;9:245-9.
7. Reis PM, Punch MR, Bove EL, van de Van CJM. Obstetric management of 219 infants with hypoplastic left heart syndrome. Am J Obstet Gynecol 1998;179:1150-4.
8. Allan LD, Sharland GK, Milburn A, Lockhart SM, Groves AM, Anderson RH, et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 1994;23:1452-8.
9. Kitchiner D. Antenatal detection of congenital heart disease. Curr Paediatr 2004;14:39-44.
10. Natowicz M, Kelley RI. Association of Turner syndrome with hypoplastic left-heart syndrome. Am J Dis Child 1987; 141:218-20.
11. Glauser TA, Zackai E, Weinberg P, Clancy R. Holt-Oram syndrome associated with the hypoplastic left heart syndrome. Clin Genet 1989;36:69-72.
12. Natowicz M, Chatten J, Clancy R. Genetic disorders and major extracardiac anomalies associated with the hypoplastic left heart syndrome. Pediatrics 1988;82:698-706.
13. Rasiah SV, Ewer AK, Miller P, Wright JG, Barron DJ, Brawn WJ, et al. Antenatal perspective of hypoplastic left heart syndrome: 5 years on. Arch Dis Child Fetal Neonatal Ed 2008;93:F192-7.
14. Quintessenza JA, Morell VO, Jacobs JP. Achieving a balance in the current approach to the surgical treatment of hypoplastic eft heart syndrome. Cardiol Young 2004;14 Suppl 1:127-30.
15. Allan LD, Apfel HD, Printz BF. Outcome after prenatal diagnosis of the hypoplastic left heart syndrome. Heart 1998; 79:371-4.
16. Allen RH, Benson CB, Haug LW. Pregnancy outcome of fetuses with a diagnosis of hypoplastic left ventricle on prenatal sonography. J Ultrasound Med 2005;24:1199-203.
17. Solveig Schulz, Rosemarie Fröber, Cornelia Kraus,Uwe Schneider. Prenatal diagnosis of hypoplastic left heart syndrome associated with Noonan syndrome and de novo RAF1 mutation. Prenatal Diagnosis 2012;32:1016-8.
18. Brackley KJ, Kilby MD, Wright JG, Brawn WJ, Sethia B, Stumper O, et al. Outcome after prenatal diagnosis of hypoplastic left-heart syndrome: a case series. Lancet 2000; 356:1143-7.
19. Noonan JA, Nadas AS. The hypoplastic left heart syndrome: an analysis of 101 cases. Pediatr Clin North Am 1958;5: 1029-56.
20. Greenwood RD, Rosenthal A, Parisi L, Fyler DC, Nadas AS. Extracardiac anomalies in infants with congenital heart disease. Pediatrics 1975;55:485-92.
21. Wallgren EI, Landtman B, Rapola J. Extracardiac malformations associated with congenital heart disease. Eur J Cardiol 1978;7:15-24.
22. Barron DJ, Kilby MD, Davies B, Wright JGC, Jones TJ, Brawn WJ. Hypoplastic left heart syndrome. Lancet 2009; 374:551-64.
23. Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RDB, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 2002;106(Suppl I):82-9.
24. Fraisse A, Nassi C, Sigaudy S, Liprandi A, Piercecchi-Marti MD, Ligi I, et al. Outcome of infants with hypoplastic left heart syndrome diagnosed in utero. [Article in French] Arch Mal Coeur Vaiss 2002;95:473-7.
25. Verheijen PM, Lisowski LA, Plantinga RF, Hitchcock F, Bennink, G, Stoutenbeek P, et al. Prenatal diagnosis of the fetus with hypoplastic left heart syndrome: management and outcome. Herz 2003;28:250-6.
26. Rizzo G, Capponi A. Fetal cardiac abnormalities. In: James DK, Steer PJ, Weiner CP, Gonik B, eds. High risk pregnancy: management options. London: Saunders/Elsevier; 2006; p: 341-69.
27. Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilen U, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005;26:2325-33.
28. Kon AA, Ackerson L, Lo B. How pediatricians counsel parents when no "best-choice" management exists: lessons to be learned from hypoplastic left heart syndrome. Arch Pediatr Adolesc Med 2004;158:436-41.
29. Razzouk AJ, Chinnock RE, Gundry SR, Johnson JK, Larsen RL, Baum MF, et al. Transplantation as a primary treatment for hypoplastic left heart syndrome: intermediate-term results. Ann Thorac Surg 1996;62:1-7.
30. Chrisant MR, Naftel DC, Drummond-Webb J, Chinnock R, Canter CE, Boucek MM, et al. Pediatric heart transplant study group fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant 2005;24:576-82.
31. Mahle WT, Spray TL, Wernovsky G, Gaynor JW, Clark BJ 3rd. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation 2000;102:III136-41.
32. Tibballs J, Kawahira Y, Carter BG, Donath S, Brizard C, Wilkinson J. Outcomes of surgical treatment of infants with hypoplastic left heart syndrome: an institutional experience 1983–2004. J Paediatr Child Health 2007;43:746-51.
33. Brosig CL, Mussatto KA, Kuhn EM, Tweddell JS. Neurodevelopmental outcome in preschool survivors of complex congenital heart disease: implications for clinical practice. J Pediatr Health Care 2007;21:3-12.
34. Forbess JM, Visconti KJ, Bellinger DC, Jonas RA. Neurodevelopmental outcomes in children after the Fontan operation. Circulation 2001;104:I127-I132.
35. Gaynor JW, Gerdes M, Nord AS, Bernbaum J, Zackai E, Wernovsky G, et al. Is cardiac diagnosis a predictor of neurodevelopmental outcome after cardiac surgery in infancy? J Thorac Cardiovasc Surg 2010;140:1230-7.
36. Goldberg CS, Schwartz EM, Brunberg JA, Mosca RS, Bove EL, Schork MA, et al. Neurodevelopmental outcome of patients after the Fontan operation: a comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J Pediatr 2000;137:646-52.
37. Mahle WT, Visconti KJ, Freier MC, Kanne SM, Hamilton WG, Sharkey AM, et al. Relationship of surgical approach to neurodevelopmental outcomes in hypoplastic left heart syndrome. Pediatrics 2006;117:e90-e97.
38. Sarajuuri A, Jokinen E, Puosi R, Mildh L, Mattila I, Lano A, et al. Neurodevelopment in children with hypoplastic left heart syndrome. J Pediatr 2010; 157:414-420; 420.e411-e414.
39. Szwast A, Tian Z, McCann M, Soffer D, Rychik J. Rychik. Comparative analysis of cerebrovascular resistance in fetuses with single-ventricle congenital heart disease. Ultrasound Obstet Gynecol 2012;40:62-7.
40. Hilton-Kamm D, Chang RK, Sklansky M. Prenatal diagnosis of hypoplastic left heart syndrome: impact of counseling patterns on parental perceptions and decisions regarding termination of pregnancy. Pediatr Cardiol 2012;33:1402-10.
2D ultrasonographic view of left ventricle hypoplasia.
While flow is seen in the right ventricle by Doppler ultrasonography,
no flow is seen in the left ventricle.